A challenging case of a patient with a family history of autoimmune disease, who presented with evidence of type 1 autoimmune hepatitis, further complicated by polyarteritis nodosa. Southern Medical Journal
Spondyloarthropathy patients who receive anti-tumor necrosis factor (TNF) therapy experience significant changes in body composition, according to a report in the May issue of The Journal of Rheumatology. Reuters Health Information
Early diagnosis of patients with rapidly progressing RA enables immediate and intensive intervention (e.g. with biologic therapy), and a greater opportunity to change the course of disease. Rheumatology
Jonathan Kay, MD, summarizes the latest updates with tumor necrosis factor inhibitor for the treatment of RA, as illustrated by data from EULAR 2008. Medscape Rheumatology
Reduction of elevated tumor necrosis factor (TNF)-alpha levels after infliximab treatment does not predict treatment response in patients with rheumatoid arthritis (RA), according to a report in the November issue of The Journal of Rheumatology. Reuters Health Information
